Lon­za breaks ground on $500M+ Swiss man­u­fac­tur­ing fa­cil­i­ty

Lon­za’s ma­jor con­struc­tion project in Switzer­land is tak­ing a big step for­ward.

The Swiss CD­MO has bro­ken ground on a fill-fin­ish man­u­fac­tur­ing site in the town of Stein, Switzer­land, about 20 miles from its head­quar­ters in Basel. The CHF 500 mil­lion ($544 mil­lion) fa­cil­i­ty was an­nounced last sum­mer and will be con­struct­ed on the same cam­pus as Lon­za’s cur­rent clin­i­cal drug prod­uct fa­cil­i­ty.

In an email to End­points News, Pe­ter Droc, the head of prod­uct ser­vices at Lon­za, said the fa­cil­i­ty is still on track for com­ple­tion, with op­er­a­tions slat­ed to start in 2026. The fa­cil­i­ty still in­tends to man­u­fac­ture large-scale com­mer­cial prod­ucts. Ad­di­tion­al­ly, Lon­za ex­pects to add around 400 full-time po­si­tions at the fa­cil­i­ty by 2026.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER